scholarly article | Q13442814 |
P50 | author | Jonathan M. Spergel | Q37370578 |
P2093 | author name string | J Pablo Abonia | |
Antonella Cianferoni | |||
P2860 | cites work | Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment | Q28252340 |
Aneurysm syndromes caused by mutations in the TGF-beta receptor | Q28259654 | ||
Eosinophilic esophagitis | Q28278849 | ||
The Genotype-Tissue Expression (GTEx) project | Q28657968 | ||
Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 | ||
Towards a knowledge-based Human Protein Atlas | Q29617987 | ||
High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. | Q30554334 | ||
TGF-beta and fibrosis | Q33804142 | ||
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis | Q33934643 | ||
Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis | Q33996008 | ||
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes | Q34030947 | ||
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. | Q34132655 | ||
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota | Q34518075 | ||
GWAS identifies four novel eosinophilic esophagitis loci | Q34545768 | ||
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up | Q34574439 | ||
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome | Q34624093 | ||
Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation | Q34892555 | ||
Circulating transforming growth factor-beta in Marfan syndrome | Q34994399 | ||
Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies | Q35085864 | ||
Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study | Q36082838 | ||
Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis | Q36113580 | ||
Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia | Q36153520 | ||
Eosinophilic esophagitis in cystic fibrosis: a case series and review of the literature. | Q36460282 | ||
Food allergies and eosinophilic gastrointestinal illness | Q36808262 | ||
Recent advances in the pathological understanding of eosinophilic esophagitis | Q37091698 | ||
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia | Q37124757 | ||
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting | Q37218675 | ||
14 years of eosinophilic esophagitis: clinical features and prognosis. | Q37378395 | ||
TGFβ receptor mutations impose a strong predisposition for human allergic disease | Q37526777 | ||
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | Q37632813 | ||
Eosinophilic esophagitis: updated consensus recommendations for children and adults | Q37863307 | ||
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). | Q38097271 | ||
Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience. | Q38193913 | ||
Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. | Q38959847 | ||
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. | Q40036792 | ||
Netherton's syndrome: a syndrome of elevated IgE and characteristic skin and hair findings | Q40570245 | ||
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis | Q41036786 | ||
Transforming growth factor beta in bovine milk: concentration, stability and molecular mass forms | Q41160583 | ||
Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells | Q41832594 | ||
Innate signals from Nod2 block respiratory tolerance and program TH2-driven allergic inflammation | Q42696069 | ||
Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. | Q42935186 | ||
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. | Q42972510 | ||
TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis--or should we really say mastocytic esophagitis? | Q42973784 | ||
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression | Q44467281 | ||
Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children | Q44471652 | ||
Rapidly increasing incidence of eosinophilic esophagitis in a large cohort | Q45110756 | ||
Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. | Q45811536 | ||
Esophageal remodeling in pediatric eosinophilic esophagitis | Q46304660 | ||
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction | Q46969232 | ||
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial | Q48509747 | ||
Identification and characterization of two novel calpain large subunit genes. | Q52128241 | ||
Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. | Q53591958 | ||
Effect of pasteurization on selected immune components of donated human breast milk | Q57713572 | ||
Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland | Q58019861 | ||
IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome | Q61843526 | ||
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial | Q61959735 | ||
Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis | Q61959737 | ||
Eosinophilic esophagitis: Escalating epidemiology? | Q61959781 | ||
Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response | Q61959815 | ||
Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula | Q71737350 | ||
Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis | Q79964941 | ||
Atopic characteristics of adult patients with eosinophilic esophagitis | Q80785407 | ||
Expression of interleukin-4 receptor α in human corneal epithelial cells | Q84206805 | ||
Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet | Q84487828 | ||
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome | Q87050240 | ||
Eosinophilic esophagitis | Q87353013 | ||
Dietary treatment of eosinophilic esophagitis | Q87844537 | ||
P433 | issue | 4 | |
P921 | main subject | eosinophilic esophagitis | Q2057356 |
P304 | page(s) | 951-955 | |
P577 | publication date | 2017-03-28 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology: In Practice | Q24056070 |
P1476 | title | Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa | |
P478 | volume | 5 |